- With the help of giant Medtronic, Mazor is enjoying considerable commercial success for its two medical robot systems.
- The business model is particularly attractive, generating a large amount of recurring revenues from an increasing installed base.
- There are still multiple growth opportunities ahead.
- Our only worry is competition isn’t sitting still, but we still think the shares have a good risk/reward profile.
Mazor Is Growing Nicely
June 3rd, 2018 · No Comments